| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.03. | UPM-Kymmene Corporation: UPM Annual Report 2023, Corporate Governance Statement, Remuneration Report and Remuneration Policy published | 65 | GlobeNewswire (Europe) | UPM-Kymmene Corporation Annual Financial Report 1 March 2024 at 9:30 EET UPM Annual Report 2023, Corporate Governance Statement, Remuneration Report and Remuneration Policy published... ► Artikel lesen | |
| 01.03. | Acconeer AB: Bulletin from the Extraordinary General Meeting in Acconeer AB | 137 | GlobeNewswire (Europe) | Acconeer AB (the "Company") has today, 1 March 2024, held an Extraordinary General Meeting (the "EGM"). The EGM resolved approve the Board of Directors' proposal to amend the Articles of Association... ► Artikel lesen | |
| 01.03. | Canadian National Railway Company: CN Reaches New Tentative Collective Agreement with United Steelworkers | 458 | GlobeNewswire (Europe) | MONTREAL, March 01, 2024 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today that a new tentative three-year collective agreement has been reached with the United Steelworkers (USW) Local... ► Artikel lesen | |
| 01.03. | Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 381 | GlobeNewswire (Europe) | DALLAS, March 01, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for... ► Artikel lesen | |
| 01.03. | Kura Oncology, Inc.: Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 356 | GlobeNewswire (Europe) | SAN DIEGO, March 01, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the "Company") (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines... ► Artikel lesen | |
| 01.03. | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 188 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 01, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address... ► Artikel lesen | |
| 01.03. | Mega Matrix Corp: Mega Matrix Announces Inspiring Operating Metrics for the First Two Months of 2024 | 300 | GlobeNewswire (Europe) | PALO ALTO, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Mega Matrix Corp. (NYSE American: MPU) (the "Company" or "MPU") today announced FlexTV's operating metrics for the first two months of 2024. Following... ► Artikel lesen | |
| 01.03. | G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 380 | GlobeNewswire (Europe) | RESEARCH TRIANGLE PARK, N.C., March 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable... ► Artikel lesen | |
| 01.03. | Power Solutions International, Inc.: Power Solutions International Appoints Randall Lehner as General Counsel | 441 | GlobeNewswire (Europe) | WOOD DALE, Ill., March 01, 2024 (GLOBE NEWSWIRE) -- Power Solutions International, Inc. (the "Company") today announced that on February 7, 2024, the Board of Directors of the Company appointed Randall... ► Artikel lesen | |
| 01.03. | Molecular Partners Announces Dismissal of Class Action Lawsuit | 324 | GlobeNewswire (Europe) | ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built... ► Artikel lesen | |
| 01.03. | Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 425 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) ("Biomea" or the "Company"), a clinical stage biopharmaceutical company focused on the discovery and development... ► Artikel lesen | |
| 01.03. | Magic Empire Global Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency | 673 | GlobeNewswire (Europe) | Hong Kong, March 01, 2024 (GLOBE NEWSWIRE) -- Magic Empire Global Limited (NASDAQ: MEGL) ("MEGL", or the "Company") announced that, on February 28, 2024, the Company received a letter from the Listing... ► Artikel lesen | |
| 01.03. | Trio Petroleum Corp.: Trio Petroleum Announces Notice of Noncompliance with NYSE American Listing Standards | 393 | GlobeNewswire (Europe) | Bakersfield, CA, March 01, 2024 (GLOBE NEWSWIRE) -- Trio Petroleum Corp (NYSE American: TPET) ("TPET", "Trio" or the "Company"), a California-based oil and gas company, today announced that on February... ► Artikel lesen | |
| 01.03. | Cipher Mining Inc.: Cipher Mining Announces February 2024 Operational Update | 247 | GlobeNewswire (Europe) | NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) ("Cipher" or the "Company") today released its unaudited production and operations update for February 2024. Key Highlights... ► Artikel lesen | |
| 01.03. | X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 359 | GlobeNewswire (Europe) | BOSTON, March 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective... ► Artikel lesen | |
| 01.03. | NurExone Biologic Inc: NurExone Presenting Novel Regulatory Pathways for Exosomes Therapies at Global Summit | 435 | GlobeNewswire (Europe) | TORONTO and HAIFA, Israel, March 01, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the "Company" or "NurExone"), a pioneering biopharmaceutical company, is pleased to... ► Artikel lesen | |
| 01.03. | Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 294 | GlobeNewswire (Europe) | WATERTOWN, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) ("Lyra" or the "Company"), a clinical-stage biotechnology company developing long-acting, anti-inflammatory... ► Artikel lesen | |
| 01.03. | Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 403 | GlobeNewswire (Europe) | BOSTON, March 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing... ► Artikel lesen | |
| 01.03. | Cytokinetics, Incorporated: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 259 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on February 29, 2024 it granted stock options to purchase an aggregate... ► Artikel lesen | |
| 01.03. | Stellantis N.V.: Weekly Report (February 28-29, 2024) on the First Tranche of Stellantis 2024 Share Buyback Program | 494 | GlobeNewswire (Europe) | Weekly Report (February 28-29, 2024) on the First Tranche of Stellantis 2024 Share Buyback Program AMSTERDAM, March 1, 2024 - Stellantis N.V. ("Stellantis" or the "Company") announced today that pursuant... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 1.683 |
| NEL | 1.669 |
| SUPER MICRO COMPUTER | 1.660 |
| NVIDIA | 1.652 |
| TUI | 1.486 |
| BAYER | 1.339 |
| RHEINMETALL | 1.000 |
| RENK GROUP | 932 |
| PROSIEBENSAT.1 | 914 |
| VOLKSWAGEN | 736 |
| AMAZON | 699 |
| PALANTIR TECHNOLOGIES | 698 |
| TESLA | 687 |
| MICROSTRATEGY | 636 |
| DEUTSCHE BANK | 586 |
| PLUG POWER | 571 |
| BASF | 565 |
| BYD | 558 |
| THYSSENKRUPP | 542 |
| COMMERZBANK | 535 |
| AIXTRON SE | 533 |
| MERCEDES-BENZ | 508 |
| SAP | 507 |
| ALLIANZ | 495 |
| DEUTSCHE TELEKOM | 474 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
